Creative Biolabs

Applications of Targeted Drug Delivery

Innovation in drug delivery systems is key to breaking through the limitations of traditional therapies and translating drug potential into clinical efficacy. In the highly complex biomedical field, precise targeting, efficient encapsulation, and controlled release are central to project success.

Creative Biolabs focuses on providing you with advanced targeted delivery solutions to help your pipeline move from the laboratory to the clinic, maximizing drug efficacy and minimizing side effects.

Why Targeted Delivery Matters?

In today's innovative drug development, whether it's small molecules, peptides, or nucleic acid and cell products, they all face common challenges that traditional systemic dosing cannot resolve:

Biological Barrier Crossing

How to effectively navigate and bypass formidable barriers, such as the blood-brain barrier (BBB), mucous membranes, or specific cell membranes, to reach deep-seated targets?

Bioavailability and Stability

How to protect sensitive, high-value drugs (such as mRNA, proteins, and gene editors) from rapid enzymatic degradation while increasing their functional concentration in vivo?

Safety & Tolerability

How to deliver drugs precisely to the lesion site (e.g., a tumor microenvironment) to achieve maximum therapeutic effect while minimizing off-target damage to healthy tissues?

Our targeted delivery platform is designed to address these core pain points, ensuring your drug works at the right time, in the right place, and at the right dose, redefining its therapeutic index.

What We Can Offer

Creative Biolabs offers a one-stop customized service covering all stages of new drug development, from carrier screening, formulation development, and process optimization to comprehensive pharmacokinetic/pharmacodynamic (PK/PD) evaluation.

With our deep biomedical expertise and cutting-edge delivery technology, we can provide:

Customized Carrier Design

We design and synthesize novel, proprietary carriers, including advanced liposomes, lipid nanoparticles (LNPs), and polymer micelles. These are tailored precisely based on your drug characteristics (small molecules, nucleic acids, proteins) and your target cells/tissues, ensuring optimal cargo protection.

Formulation Process Optimization

We establish stable, scalable, manufacturing processes to ensure high drug loading efficiency, exceptional stability, and superior batch consistency, accelerating your transition to clinical trials.

Precise Targeting Modification

We achieve active targeting through proprietary ligand linking, antibody conjugation, and other advanced techniques to significantly enhance drug accumulation at lesion sites, even at the subcellular level.

In Vitro & In Vivo Evaluation Support

We provide end-to-end support, including rigorous in vitro release profiles, cellular uptake studies, and comprehensive animal model analyses (PK/PD and biodistribution) to secure your preclinical success.

Applications

Advanced Therapeutic Payload Delivery

Our solutions are essential for successfully advancing complex, modern treatments. This includes protecting and delivering sensitive payloads for Gene Therapy (mRNA, siRNA, CRISPR components), enhancing targeted action for Immunotherapy and Cell Therapy, and significantly improving the safety profile of conventional Chemotherapy agents.

Broad Commercial & Non-Pharma Applications

Our core delivery expertise transcends human medicine. We actively support development beyond the core Biomedical sector and Diagnostics, leveraging our nanocarrier technology for high-value commercial areas such as cosmetics, animal health, and plant science/agritech formulations.

Precision Targeting for Critical Disease States

We focus our delivery technology on crucial disease categories where current treatments fail due to systemic toxicity or poor targeting. This includes enhancing penetration for CNS Diseases (crossing the BBB), achieving localized effect in oncotherapy, and resolving chronic issues in inflammatory/autoimmune conditions.

Optimized Drug Performance Across Delivery Routes

We engineer carriers to function effectively regardless of how the drug is administered. This is vital for optimizing challenging delivery paths like Oral administration (surviving the GI tract), Pulmonary delivery (deep lung targeting), and specialized access routes like Intracranial injection.

Schematic of the mechanism of nanoparticles and applications of nanoparticles in tumour-targeted drug delivery and vaccine. (OA Literature)Fig.1 Mechanism of nanoparticles and applications in tumor targeted drug delivery.1

Explore Our Solutions by Application Category

To help you quickly find the solution best suited to your project needs, we have categorized our expertise across multiple dimensions based on specific targeted delivery application areas.

Click the titles below to learn more about our expertise in each sub-field.

1. By Therapy

Chemotherapy

Immunotherapy

Cell Therapy

Gene Therapy

Regenerative Medicine

Protein Replacement Therapy

Enzyme Replacement Therapy

Sonodynamic Therapy

Photodynamic Therapy

Combination Therapy

Immunology

2. By Industry

Biomedical Research

Diagnostics & Imaging

Food & Nutrition

Cosmetics

Animal Health

Plant Science & Agritech

Energy Field

Industrial & Material Field

3. By Therapeutic Area

Oncology

CNS Diseases

Metabolic Diseases

Musculoskeletal Diseases

Genetic Blood Disorders

Inflammatory & Autoimmune Diseases

Infectious Diseases

Cardiovascular Diseases

Ophthalmic Diseases

Respiratory Diseases

Dermatology

Renal & Urinary Diseases

Pain Management

4. Routes of Administration

Oral

Parenteral

Topical & Transdermal

Inhalation & Nasal

Ophthalmic Administration

Pulmonary Administration

Intracranial Administration

Rectal Administration

Workflow

Service workflow at Creative Biolabs. (Creative Biolabs Original)

Contact our experts now! Your next innovative project awaits a breakthrough delivery technology. Please schedule a free consultation, and let us tailor a customized targeted delivery solution to accelerate your drug development process.

Reference

  1. Tu, Yuhan, et al. "Application of nanoparticles in tumour targeted drug delivery and vaccine." Frontiers in Nanotechnology 4 (2022): 948705. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fnano.2022.948705.
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry

Customer Review

Creatibe Biolabs' custom LNP was the only solution that successfully delivered our CRISPR-Cas9 payload across the blood-brain barrier with high efficiency and low toxicity.”

Dr. Evelyn Reed

Postdoctoral Researcher, Leading University

Our siRNA candidate was failing due to off-target toxicity, but Creatibe Biolabs' team rapidly redesigned our LNP using their modular platform, rescuing our preclinical program.”

Ben Carter

Project Manager

Achieving cytosolic delivery of our protein degrader with Creatibe Biolabs' exosome platform was the key to unlocking our candidate's full therapeutic potential.”

Dr. Kenji Tanaka

Principal Scientist, Large Pharma Corp

Our oncology drug's efficacy was limited by poor tumor accumulation. Creatibe Biolabs' peptide-conjugated liposomes provided the precise targeting we needed, dramatically increasing the drug's therapeutic index.”

Dr. Clara Schmidt

Senior Scientist, Oncology Innovations Inc.

We required a delivery system that would only release its payload in the tumor's acidic microenvironment. Creatibe Biolabs' pH-responsive liposomes performed flawlessly, minimizing systemic exposure.”

David Chen

Formulation Scientist

Outstanding expertise in antibody engineering.The team's attention to detail and innovative approaches have sianificantly accelerated our development timeline.

Sarah L.

Senior Research Scientist

Contact us for more information Get free consultations
ad